APOM and COVID-19: Further interesting findings of our study refer to the relation between S1P (and apoM) and the established inflammation marker NLR, as well as the clinical prediction tool PSI, both found correlated with COVID‐19 severity (Ciccullo et al, 2020; Satici et al, 2020).